FATE Insider Trading

Insider Ownership Percentage: 5.00%
Insider Buying (Last 12 Months): $166,023.60
Insider Selling (Last 12 Months): $202,409.98

Fate Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Fate Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fate Therapeutics Share Price & Price History

Current Price: $2.02
Price Change: Price Decrease of -0.06 (-2.88%)
As of 11/15/2024 01:00 AM ET

This chart shows the closing price history over time for FATE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Fate Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/6/2024Yuan XuDirectorSell633$4.23$2,677.598,669View SEC Filing Icon  
1/29/2024Edward J. Dulac, IIICFOSell1,849$5.00$9,245.00103,926View SEC Filing Icon  
1/9/2024Bahram ValamehrInsiderSell11,271$4.38$49,366.98158,069View SEC Filing Icon  
1/9/2024Cindy TahlGeneral CounselSell10,874$4.37$47,519.38142,361View SEC Filing Icon  
1/9/2024Edward J. Dulac, IIICFOSell7,028$4.37$30,712.36105,775View SEC Filing Icon  
1/9/2024J. Scott WolchkoCEOSell14,391$4.37$62,888.67371,248View SEC Filing Icon  
12/26/2023Redmile Group, LlcDirectorBuy44,630$3.72$166,023.6013,180,388View SEC Filing Icon  
8/18/2023Edward J. Dulac, IIICFOSell4,718$2.80$13,210.40119,570View SEC Filing Icon  
8/4/2023Yuan XuDirectorSell632$3.71$2,344.729,302View SEC Filing Icon  
7/5/2023Brian T PowlInsiderSell3,854$4.87$18,768.9841,146View SEC Filing Icon  
7/5/2023Edward J. Dulac, IIICFOSell5,182$4.83$25,029.06124,288View SEC Filing Icon  
6/14/2023Yuan XuDirectorSell3,460$5.58$19,306.809,934View SEC Filing Icon  
4/20/2023Redmile Group, LlcDirectorBuy20,000$5.99$119,800.0012,879,119View SEC Filing Icon  
4/18/2023Yu-Waye ChuInsiderSell2,532$6.57$16,635.24140,676View SEC Filing Icon  
4/14/2023Redmile Group, LlcDirectorBuy25,700$6.00$154,200.0012,859,119View SEC Filing Icon  
1/13/2023John MendleinDirectorBuy36,631$5.43$198,906.33282,770View SEC Filing Icon  
1/11/2023John MendleinDirectorBuy88,048$5.67$499,232.16246,139View SEC Filing Icon  
1/10/2023Bahram ValamehrInsiderSell10,917$5.24$57,205.08168,917View SEC Filing Icon  
1/10/2023Cindy TahlGeneral CounselSell11,553$5.24$60,537.72177,598View SEC Filing Icon  
1/10/2023Edward J. Dulac, IIICFOSell7,331$5.24$38,414.44129,470View SEC Filing Icon  
1/10/2023J. Scott WolchkoCEOSell45,907$5.24$240,552.68385,639View SEC Filing Icon  
8/18/2022Edward J. Dulac, IIICFOSell5,135$29.81$153,074.35136,801View SEC Filing Icon  
7/21/2022J. Scott WolchkoCEOSell30,000$32.88$986,400.00431,546View SEC Filing Icon  
7/7/2022Bahram ValamehrInsiderSell17,158$30.23$518,686.34179,834View SEC Filing Icon  
7/5/2022Mark PlavsicInsiderSell3,719$24.61$91,524.59127,123View SEC Filing Icon  
6/7/2022Shefali AgarwalDirectorSell841$21.89$18,409.491,840View SEC Filing Icon  
6/3/2022John MendleinDirectorSell1,364$22.79$31,085.56158,091View SEC Filing Icon  
4/21/2022J. Scott WolchkoCEOSell30,000$35.00$1,050,000.00431,546View SEC Filing Icon  
4/19/2022Yu-Waye ChuInsiderSell4,062$35.37$143,672.94151,033View SEC Filing Icon  
4/1/2022Cindy TahlGeneral CounselSell25,000$38.85$971,250.00189,151View SEC Filing Icon  
3/10/2022John MendleinDirectorSell31,562$35.02$1,105,301.24View SEC Filing Icon  
1/20/2022J. Scott WolchkoCEOSell30,000$40.21$1,206,300.00View SEC Filing Icon  
1/11/2022Edward J. Dulac, IIICFOSell1,770$48.45$85,756.50View SEC Filing Icon  
1/11/2022Yu-Waye ChuVPSell3,965$48.51$192,342.15View SEC Filing Icon  
1/10/2022Bahram ValamehrInsiderSell5,596$46.38$259,542.48View SEC Filing Icon  
1/10/2022Cindy TahlGeneral CounselSell7,738$46.43$359,275.34View SEC Filing Icon  
1/10/2022J. Scott WolchkoCEOSell34,156$46.86$1,600,550.16View SEC Filing Icon  
12/20/2021Edward J. Dulac, IIICFOSell15,977$60.00$958,620.00View SEC Filing Icon  
12/13/2021Bahram ValamehrInsiderSell25,000$47.66$1,191,500.00View SEC Filing Icon  
12/10/2021Yu-Waye ChuVPSell7,500$51.46$385,950.00View SEC Filing Icon  
11/18/2021J. Scott WolchkoCEOSell20,000$54.27$1,085,400.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

97.54% of Fate Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FATE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Fate Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC2,258,246$7.91M0.0%+0.5%1.983%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC424,277$1.49M0.0%+245.3%0.373%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC147,872$0.52M0.0%-32.1%0.130%Search for SEC Filing on Google Icon
11/15/2024State Street Corp5,252,974$18.39M0.0%-1.6%4.613%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp24,096$84K0.0%-41.9%0.021%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.1,587,900$5.56M0.0%-6.3%1.394%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP1,685,000$5.90M0.4%-15.8%1.480%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC67,609$0.24M0.0%+263.5%0.059%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC142,131$0.50M0.0%-24.6%0.125%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC42,652$0.15M0.0%-28.9%0.037%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets174,148$0.61M0.0%+1,307.6%0.153%Search for SEC Filing on Google Icon
11/13/2024FMR LLC227,981$0.80M0.0%+25.9%0.200%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.763,808$2.67M0.0%-13.1%0.671%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC30,946$0.11M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/7/2024Thrivent Financial for Lutherans125,370$0.44M0.0%+24.7%0.110%Search for SEC Filing on Google Icon
11/6/2024Cornercap Investment Counsel Inc.20,683$72K0.0%-52.4%0.018%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.12,078$42K0.0%-88.4%0.011%Search for SEC Filing on Google Icon
11/2/2024Privium Fund Management B.V.50,000$0.18M0.0%N/A0.044%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.2,434,198$8.52M0.0%-5.5%2.138%Search for SEC Filing on Google Icon
10/21/2024Castleview Partners LLC20,826$73K0.0%N/A0.018%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC42,289$0.15M0.0%+40.7%0.037%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC345,575$1.13M0.0%N/A0.304%Search for SEC Filing on Google Icon
8/16/2024Doheny Asset Management CA7,670$0.26M0.1%N/A0.007%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC65,611$0.22M0.0%+318.4%0.058%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC262,414$0.86M0.0%+73.6%0.231%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company39,715$0.13M0.0%-33.6%0.035%Search for SEC Filing on Google Icon
8/15/2024Dark Forest Capital Management LP19,065$63K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C3,555,871$11.66M0.2%+62.3%3.124%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC16,460$54K0.0%-25.5%0.014%Search for SEC Filing on Google Icon
8/15/2024Caxton Associates LP172,863$0.57M0.0%-40.4%0.152%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC128,759$0.42M0.0%N/A0.113%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP330,082$1.08M0.0%-4.4%0.290%Search for SEC Filing on Google Icon
8/14/2024Integral Health Asset Management LLC850,000$2.79M0.3%+325.0%0.747%Search for SEC Filing on Google Icon
8/14/2024DRW Securities LLC21,550$71K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC11,351$37K0.0%-25.5%0.010%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC46,528$0.15M0.0%-58.6%0.041%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd33,898$0.11M0.0%+95.0%0.030%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC88,514$0.28M0.0%+34.3%0.078%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.355,225$1.17M0.1%+930.2%0.312%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC548,544$1.80M0.0%N/A0.482%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP2,130,280$6.99M0.0%+100.4%1.871%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA167,055$0.55M0.0%+3.5%0.147%Search for SEC Filing on Google Icon
8/9/2024Bruce & Co. Inc.300,000$0.98M0.3%+109.8%0.264%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.1,031,505$3.38M0.0%+2.4%0.906%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.166,255$0.55M0.0%+26.4%0.146%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC28,508$94K0.0%+5,258.6%0.025%Search for SEC Filing on Google Icon
8/7/2024Doheny Asset Management CA7,670$0.26M0.2%N/A0.007%Search for SEC Filing on Google Icon
8/7/2024Monaco Asset Management SAM286,900$0.94M0.1%-9.4%0.252%Search for SEC Filing on Google Icon
8/6/2024Ausdal Financial Partners Inc.10,007$33K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC2,008,862$6.59M0.0%+17.2%1.765%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System25,486$84K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.104,019$0.34M0.0%-43.5%0.091%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers160,001$0.53M0.0%+11.0%0.141%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.13,668$45K0.0%-42.8%0.012%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp374,132$1.23M0.0%+23.9%0.329%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.2,574,703$8.45M0.0%+1.0%2.262%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.360,311$2.65M0.1%N/A0.317%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System8,520$63K0.0%-38.9%0.007%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.1,999,822$14.68M0.1%-23.6%1.757%Search for SEC Filing on Google Icon
5/16/2024Bayesian Capital Management LP39,800$0.29M0.0%+102.7%0.035%Search for SEC Filing on Google Icon
5/16/2024Caxton Associates LP290,187$2.13M0.1%N/A0.255%Search for SEC Filing on Google Icon
5/15/2024Baker BROS. Advisors LP1,818,181$13.35M0.2%N/A1.597%Search for SEC Filing on Google Icon
5/15/2024Public Employees Retirement System of Ohio147,799$1.09M0.0%-4.1%0.130%Search for SEC Filing on Google Icon
5/15/2024Bellevue Group AG4,839,779$35.52M0.5%-0.2%4.252%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD274,289$2.01M0.0%+404.6%0.241%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC1,714,124$12.58M0.0%-24.9%1.506%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.9,911,007$72.75M0.0%+6.6%8.708%Search for SEC Filing on Google Icon
5/9/2024Monaco Asset Management SAM316,805$2.33M0.7%-85.5%0.278%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.110,248$0.81M0.0%-52.8%0.097%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC151,121$1.11M0.1%N/A0.133%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC37,456$0.28M0.0%-58.6%0.033%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets46,962$0.35M0.0%+100.9%0.041%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.58,835$0.43M0.0%N/A0.052%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.23,876$0.18M0.0%-10.9%0.021%Search for SEC Filing on Google Icon
4/24/2024Simplicity Wealth LLC11,016$81K0.0%N/A0.010%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.2,548,304$18.71M0.0%+1,462.4%2.239%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP146,100$0.55M0.1%N/A0.148%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP847,823$3.17M2.3%N/A0.860%Search for SEC Filing on Google Icon
2/14/2024Vestal Point Capital LP1,290,000$4.83M0.5%N/A1.308%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC15,233$57K0.0%-62.7%0.015%Search for SEC Filing on Google Icon
2/12/2024Bruce & Co. Inc.143,000$0.54M0.2%-28.5%0.145%Search for SEC Filing on Google Icon
2/12/2024RPO LLC12,307$46K0.1%N/A0.012%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.356,740$1.33M0.0%-16.4%0.362%Search for SEC Filing on Google Icon
2/8/2024Vanguard Personalized Indexing Management LLC12,357$46K0.0%-13.9%0.013%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM2,183,228$8.17M2.4%+18.1%2.214%Search for SEC Filing on Google Icon
2/6/2024National Bank of Canada FI7,000$26K0.0%-41.7%0.007%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.12,504$47K0.0%+22.8%0.013%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.233,748$0.87M0.0%+34.0%0.237%Search for SEC Filing on Google Icon
1/31/2024Knights of Columbus Asset Advisors LLC32,184$0.12M0.0%+100.0%0.033%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.1,849,872$6.92M0.0%-24.5%1.876%Search for SEC Filing on Google Icon
1/26/2024Cerity Partners LLC32,174$0.12M0.0%N/A0.033%Search for SEC Filing on Google Icon
1/25/2024Nisa Investment Advisors LLC16,840$63K0.0%+1,069.4%0.017%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.163,097$0.61M0.0%-57.2%0.165%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC90,553$0.34M0.0%+23.0%0.092%Search for SEC Filing on Google Icon
1/11/2024Epiq Partners LLC10,071$38K0.0%N/A0.010%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC63,725$0.24M0.0%+34.0%0.065%Search for SEC Filing on Google Icon
12/19/2023Public Employees Retirement System of Ohio154,178$0.33M0.0%+14.7%0.156%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.10,908,351$23.13M0.0%-7.0%11.063%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.2,389,123$5.07M0.0%+2.3%2.423%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP35,173$75K0.0%+128.6%0.036%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Fate Therapeutics logo
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Read More on Fate Therapeutics

Today's Range

Now: $2.02
Low: $1.96
High: $2.12

50 Day Range

MA: $3.11
Low: $2.02
High: $4.02

52 Week Range

Now: $2.02
Low: $1.96
High: $8.83

Volume

1,752,594 shs

Average Volume

1,503,266 shs

Market Capitalization

$230.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of Fate Therapeutics?

Fate Therapeutics' top insider investors include:
  1. Redmile Group, Llc (Director)
  2. J Scott Wolchko (CEO)
  3. John Mendlein (Director)
  4. Cindy Tahl (General Counsel)
  5. Bahram Valamehr (Insider)
  6. Yu-Waye Chu (Insider)
  7. Edward J Dulac III (CFO)
  8. Brian T Powl (Insider)
  9. Yuan Xu (Director)
Learn More about top insider investors at Fate Therapeutics.

Who are the major institutional investors of Fate Therapeutics?

Fate Therapeutics' top institutional investors include:
  1. State Street Corp — 4.61%
  2. Assenagon Asset Management S.A. — 2.14%
  3. Geode Capital Management LLC — 1.98%
  4. Vestal Point Capital LP — 1.48%
  5. Jacobs Levy Equity Management Inc. — 1.39%
  6. Charles Schwab Investment Management Inc. — 0.67%
Learn More about top institutional investors of Fate Therapeutics stock.

Which institutional investors are selling Fate Therapeutics stock?

Within the previous quarter, FATE stock was sold by these institutional investors:
  1. Vestal Point Capital LP
  2. Assenagon Asset Management S.A.
  3. Charles Schwab Investment Management Inc.
  4. Jacobs Levy Equity Management Inc.
  5. Victory Capital Management Inc.
  6. State Street Corp
  7. Jane Street Group LLC
  8. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
In the last year, company insiders that have sold Fate Therapeutics company stock include:
  1. Redmile Group, Llc (Director)
  2. J Scott Wolchko (CEO)
  3. John Mendlein (Director)
  4. Cindy Tahl (General Counsel)
  5. Bahram Valamehr (Insider)
Learn More investors selling Fate Therapeutics stock.

Which institutional investors are buying Fate Therapeutics stock?

During the previous quarter, FATE stock was acquired by institutional investors including:
  1. Barclays PLC
  2. BNP Paribas Financial Markets
  3. Privium Fund Management B.V.
  4. Walleye Capital LLC
  5. FMR LLC
  6. Intech Investment Management LLC
  7. Thrivent Financial for Lutherans
  8. Castleview Partners LLC
Within the last year, these company insiders have bought Fate Therapeutics stock:
  1. Redmile Group, Llc (Director)
  2. J Scott Wolchko (CEO)
Learn More investors buying Fate Therapeutics stock.